Drug:
Reaction: PRODUCT USE IN UNAPPROVED INDICATION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491670 |
US |
56 | 2 |
Pruritus, Neurodermatitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2 | 25491895 |
US |
47 | 2 |
Illness, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 3 | 25491918 |
US |
47 | 2 |
Rebound eczema, Pruritus, Dry skin, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 4 | 25491927 |
PT |
48 | 2 |
Venous thrombosis, Product use in unapproved indication, |
||||
SEMAGLUTIDE, PANTOPRAZOLE, |
||||
| 5 | 25491978 |
US |
||
Erythema, Condition aggravated, Rash, Product use in unapproved indication, |
||||
CALCIPOTRIENE, |
||||
| 6 | 25491984 |
US |
||
Product use in unapproved indication, |
||||
ALCLOMETASONE DIPROPIONATE, |
||||
| 7 | 25491988 |
US |
58 | 2 |
Treatment failure, Product use in unapproved indication, |
||||
RILUZOLE, GABAPENTIN, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, DALFAMPRIDINE, BACLOFEN, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, BOTULINUM TOXIN TYPE A, AMANTADINE, MIRTAZAPINE, PANTOPRAZOLE, MODAFINIL, HUMAN IMMUNOGLOBULIN G, VORTIOXETINE, ROSUVASTATIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 8 | 25492039 |
US |
2 | |
Muscle spasms, Discomfort, Pain, Product use in unapproved indication, Insomnia, |
||||
| 9 | 25492168 |
CA |
2 | |
Pulmonary fibrosis, Pemphigus, Product use in unapproved indication, Psoriatic arthropathy, Pneumonia, Red blood cell sedimentation rate increased, Pericarditis, Pyrexia, Prescribed overdose, Prescribed underdose, Rash, Peripheral swelling, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, APREMILAST, ATOMOXETINE, ATOMOXETINE, CANDESARTAN, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CYCLOBENZAPRINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, PANTOPRAZOLE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RANITIDINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ERENUMAB-AOOE, RAMIPRIL, RAMIPRIL, RAMIPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, AZELAIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, SARILUMAB, LEVOMILNACIPRAN, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, PHENYLEPHRINE HYDROCHLORIDE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, CELECOXIB, |
||||
| 10 | 25492414 |
CA |
80 | 1 |
Appendicitis, Aortic stenosis, Ascites, Aspiration, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Cardiogenic shock, Congenital hiatus hernia, Diabetes mellitus, End stage renal disease, Hypoxia, Lower respiratory tract infection, Malignant melanoma stage 0, Multiple organ dysfunction syndrome, Myasthenia gravis, Pulmonary embolism, Pulmonary fibrosis, Sepsis, Thrombosis, Ventricular fibrillation, Off label use, Incorrect route of product administration, Intentional product misuse, Product dose omission issue, Product use in unapproved indication, |
||||
INSULIN ASPART, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ALLOPURINOL, AMIODARONE HYDROCHLORIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, HYDROCORTISONE ACETATE, LANSOPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, WARFARIN SODIUM, WARFARIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, SODIUM FERRIC GLUCONATE COMPLEX, |
||||
| 11 | 25492497 |
CA |
||
Abdominal pain, Adjustment disorder with depressed mood, Amnesia, Anxiety, Asthma, Autoimmune disorder, Bursitis, Chest pain, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Discomfort, Dislocation of vertebra, Dyspnoea, Ear pain, Fatigue, Gastrointestinal disorder, Grip strength decreased, Headache, Hepatic enzyme, Hypersensitivity, Hypocholesterolaemia, Ill-defined disorder, Injury, Insomnia, Musculoskeletal pain, No adverse event, Osteoarthritis, Pericarditis, Peripheral swelling, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Systemic lupus erythematosus, Taste disorder, Urticaria, Wheezing, Adverse drug reaction, Infection, Sinusitis, Contraindicated product administered, Product use in unapproved indication, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, HAMAMELIS VIRGINIANA, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, RANITIDINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LORAZEPAM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, |
||||
| 12 | 25492544 |
US |
60 | 1 |
Product use in unapproved indication, |
||||
TEMOZOLOMIDE, |
||||
| 13 | 25492548 |
IT |
75 | 2 |
Arteriospasm coronary, Product use in unapproved indication, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OXYGEN, 0XYGEN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CHLORPHENIRAMINE MALEATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, EPINEPHRINE, ADRENALINUM, TICAGRELOR, NITROGLYCERIN, RIVAROXABAN, |
||||
| 14 | 25492558 |
US |
1 | |
Hip fracture, Product use in unapproved indication, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 15 | 25492797 |
CN |
37 | 1 |
Renal impairment, Hepatic function abnormal, Product use in unapproved indication, |
||||
DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, RIFAMPIN, RIFAMPIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 16 | 25492821 |
CN |
38 | 2 |
Neuropathy peripheral, Nicotinic acid deficiency, Vitamin B complex deficiency, Product use in unapproved indication, |
||||
RIFAMPIN, ETHAMBUTOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE TABLET, PYRAZINAMIDE, CYCLOSERINE, RIFAPENTINE, PREDNISONE, |
||||
| 17 | 25492849 |
US |
2 | 2 |
Cardiac failure congestive, Cardiotoxicity, Product use in unapproved indication, Product use issue, |
||||
CARBOPLATIN, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 18 | 25493000 |
US |
1 | |
Hallucination, Hallucination, auditory, Liver injury, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 19 | 25493018 |
CN |
12 | 1 |
Osteonecrosis, Cauda equina syndrome, Neurotoxicity, Rhabdomyolysis, Toxicity to various agents, Acute kidney injury, Paralysis, Loss of consciousness, Pneumonia, Liver injury, Oedema, Sinus arrhythmia, Peroneal nerve injury, Posterior tibial nerve injury, Cough, Pain in extremity, Loss of proprioception, Sensory disturbance, Peroneal nerve palsy, Hyperreflexia, Tremor, Product use in unapproved indication, |
||||
CARBAMAZEPINE, |
||||
| 20 | 25493081 |
US |
69 | 2 |
Mycobacterium avium complex infection, Condition aggravated, Drug resistance, Product use in unapproved indication, |
||||
RIFAMPIN, RIFAMPIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AMIKACIN, |
||||
| 21 | 25493104 |
US |
83 | 2 |
Death, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, MORPHINE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DONEPEZIL HYDROCHLORIDE, GABAPENTIN, SERTRALINE, ERGOCALCIFEROL, OXYBUTYNIN CHLORIDE, |
||||
| 22 | 25493118 |
ES |
24 | 2 |
Hepatocellular injury, Coagulopathy, Intentional overdose, Drug interaction, Product use in unapproved indication, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 23 | 25493231 |
US |
2 | |
Erythema, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
NIRAPARIB, NIRAPARIB, |
||||
| 24 | 25493349 |
US |
2 | |
Disorientation, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, VALBENAZINE, |
||||
| 25 | 25493354 |
US |
2 | |
Systemic lupus erythematosus, Product use in unapproved indication, |
||||
BELIMUMAB, BELIMUMAB, BELIMUMAB, |
||||
| 26 | 25493363 |
US |
2 | |
Product use in unapproved indication, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 27 | 25493375 |
GB |
||
Cognitive disorder, Deep vein thrombosis, Anaemia, Weight decreased, Intensive care unit acquired weakness, Haematuria traumatic, Liver function test abnormal, Fungal infection, Infection, Muscle contracture, Thrombophlebitis, Product use in unapproved indication, Off label use, Intentional product use issue, |
||||
ACYCLOVIR, LACOSAMIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, VALPROATE SODIUM, PHENYTOIN, TOPIRAMATE, TOPIRAMATE SPINKLE, PHENOBARBITAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, PROPOFOL, CLONAZEPAM, CLOBAZAM, LORAZEPAM, FENTANYL, PERAMPANEL, |
||||
| 28 | 25493383 |
DE |
76 | 1 |
Epistaxis, Somnolence, Product use in unapproved indication, Asthenia, General physical health deterioration, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 29 | 25493384 |
US |
||
Drug effective for unapproved indication, Product use in unapproved indication, |
||||
ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, |
||||
| 30 | 25493610 |
US |
27 | 2 |
Seizure, Loss of consciousness, Device breakage, Incorrect product administration duration, Product use in unapproved indication, |
||||
ETONOGESTREL, ETONOGESTREL, |
||||
| 31 | 25493679 |
CN |
11 | 1 |
Cerebral venous sinus thrombosis, Cerebral infarction, Pneumonia, Upper respiratory tract infection, Product use in unapproved indication, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 32 | 25493746 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Prescribed underdose, Off label use, Prescribed overdose, Product use in unapproved indication, Product use in unapproved indication, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ERENUMAB-AOOE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, CYCLOBENZAPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, AZELAIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEVOMILNACIPRAN, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, OXYCODONE, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, |
||||
| 33 | 25493831 |
GB |
2 | |
Hepatitis, Liver function test abnormal, Hepatic steatosis, Product use in unapproved indication, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 34 | 25493873 |
US |
37 | 1 |
Hospitalisation, Incorrect product administration duration, Product use in unapproved indication, |
||||
CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROCHLORIDE, MELATONIN, |
||||
| 35 | 25493987 |
US |
82 | 1 |
Cardiac failure congestive, Blood pressure abnormal, Abnormal behaviour, Decreased appetite, Gait inability, Dyskinesia, Fatigue, Somnolence, Drug ineffective, Therapy interrupted, Product use in unapproved indication, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 36 | 25494011 |
US |
||
Injection site induration, Injection site swelling, Injection site erythema, Injection site pruritus, Product use in unapproved indication, Product preparation issue, |
||||
INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, |
||||
| 37 | 25494053 |
CA |
43 | 2 |
Blepharospasm, Contraindicated product administered, Decreased appetite, Drug ineffective, Epilepsy, Gastrooesophageal reflux disease, Hypoaesthesia, Malaise, Memory impairment, Migraine, Off label use, Pain, Product quality issue, Product use in unapproved indication, Rheumatic fever, Rheumatoid factor positive, Swollen joint count increased, Taste disorder, Treatment failure, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CAFFEINE CITRATE, CALCIUM GLUCONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, |
||||
| 38 | 25494060 |
US |
||
Off label use, Product use in unapproved indication, |
||||
INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, |
||||
| 39 | 25494078 |
US |
59 | 2 |
Death, Drug effective for unapproved indication, Product use in unapproved indication, Vasospasm, Cerebral haemorrhage, |
||||
HYDROXOCOBALAMIN, HYDROXOCOBALAMIN, NIMODIPINE, VASOPRESSIN, PROPOFOL, EPINEPHRINE, ADRENALINUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, CLEVIDIPINE, |
||||
| 40 | 25494420 |
CN |
14 | 2 |
Initial insomnia, Depressed mood, Fatigue, Tearfulness, Product prescribing issue, Product use in unapproved indication, |
||||
DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 41 | 25494443 |
KR |
2 | |
Angioedema, Product use in unapproved indication, |
||||
CELECOXIB, |
||||
| 42 | 25494454 |
RO |
72 | 1 |
Severe cutaneous adverse reaction, Product use in unapproved indication, |
||||
GABAPENTIN, GABAPENTIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, AMLODIPINE, |
||||
| 43 | 25494479 |
CN |
42 | 2 |
Malignant neoplasm progression, Product use in unapproved indication, Brain oedema, |
||||
TEMOZOLOMIDE, BEVACIZUMAB, |
||||
| 44 | 25494497 |
US |
25 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Product use in unapproved indication, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 45 | 25494570 |
KR |
2 | |
Angioedema, Product use in unapproved indication, |
||||
CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, |
||||
| 46 | 25494573 |
KR |
2 | |
Angioedema, Product use in unapproved indication, |
||||
CELECOXIB, |
||||
| 47 | 25494589 |
CN |
55 | 1 |
Chest discomfort, Palpitations, Flushing, Pruritus, Oxygen saturation decreased, Rash, Product use in unapproved indication, |
||||
LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 48 | 25494696 |
US |
2 | |
Hypersensitivity, Pruritus, Dyspnoea, Condition aggravated, Product use in unapproved indication, Intentional product misuse, |
||||
PERMETHRIN, |
||||
| 49 | 25494705 |
US |
78 | 1 |
Pneumonitis, Product use in unapproved indication, |
||||
DAPTOMYCIN, |
||||
| 50 | 25494729 |
US |
2 | |
Hypersensitivity, Product use in unapproved indication, |
||||
| 51 | 25494992 |
US |
16 | 1 |
Weight increased, Product use in unapproved indication, |
||||
LARONIDASE, |
||||
| 52 | 25495056 |
AU |
64 | 1 |
Febrile neutropenia, Peripheral sensory neuropathy, Product use in unapproved indication, Drug ineffective, |
||||
FILGRASTIM, LENALIDOMIDE, LENALIDOMIDE, BRENTUXIMAB VEDOTIN, |
||||
| 53 | 25495065 |
US |
||
Product prescribing issue, Product use in unapproved indication, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 54 | 25495166 |
US |
1 | |
Drug effective for unapproved indication, Product administered at inappropriate site, Product use in unapproved indication, |
||||
DICLOFENAC SODIUM, |
||||
| 55 | 25495269 |
US |
2 | |
Product use in unapproved indication, |
||||
PEMBROLIZUMAB, CISPLATIN, ETOPOSIDE, LENVATINIB, |
||||
| 56 | 25495373 |
US |
2 | |
Intentional product misuse, Vaginal haemorrhage, Product use in unapproved indication, |
||||
LEVONORGESTREL, |
||||
| 57 | 25495375 |
US |
2 | |
Intentional product misuse, Back pain, Breast pain, Product use in unapproved indication, |
||||
LEVONORGESTREL, |
||||
| 58 | 25495382 |
US |
23 | 2 |
Vaginal haemorrhage, Intentional product misuse, Product use in unapproved indication, Bacterial vaginosis, Vaginal odour, Pregnancy after post coital contraception, Drug ineffective, |
||||
LEVONORGESTREL, |
||||
| 59 | 25495384 |
US |
27 | 2 |
Intentional product misuse, Vaginal haemorrhage, Product use in unapproved indication, Abdominal discomfort, Vaginal haemorrhage, Muscle spasms, Heavy menstrual bleeding, |
||||
LEVONORGESTREL, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, NORGESTREL, |
||||
| 60 | 25495557 |
US |
2 | |
Depressed mood, Product use in unapproved indication, |
||||
DUPILUMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, BUSPIRONE HYDROCHLORIDE, LAMOTRIGINE, LISINOPRIL, PRUCALOPRIDE, NALOXEGOL OXALATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, PROPRANOLOL HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, TOPIRAMATE, |
||||
| 61 | 25495560 |
US |
60 | 1 |
Drug ineffective, Product use in unapproved indication, |
||||
SARILUMAB, |
||||
| 62 | 25495565 |
US |
2 | |
Skin burning sensation, Pruritus, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 63 | 25495572 |
US |
73 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 64 | 25495583 |
US |
14 | 2 |
Injection site pain, Injection site erythema, Injection site swelling, Product use in unapproved indication, Product preparation error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 65 | 25495591 |
US |
2 | |
Diarrhoea, Product use in unapproved indication, |
||||
SARILUMAB, |
||||
| 66 | 25495592 |
US |
14 | 1 |
Product use in unapproved indication, |
||||
BELUMOSUDIL, |
||||
| 67 | 25495594 |
US |
2 | |
Injection site bruising, Product use in unapproved indication, |
||||
DUPILUMAB, PREGABALIN, VALSARTAN, VALSARTAN ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, GABAPENTIN, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 68 | 25495625 |
US |
1 | |
Ocular hyperaemia, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 69 | 25495649 |
US |
9 | 1 |
Psoriasis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 70 | 25495653 |
US |
68 | 2 |
Gait disturbance, Pain, Activities of daily living decreased, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 71 | 25495676 |
US |
48 | 1 |
Dermatitis contact, Condition aggravated, Neurodermatitis, Product use in unapproved indication, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 72 | 25495696 |
US |
54 | 1 |
Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 73 | 25495698 |
US |
55 | 2 |
Paranasal sinus discomfort, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, |
||||
| 74 | 25495703 |
US |
50 | 2 |
Product use in unapproved indication, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 75 | 25495706 |
US |
54 | 2 |
Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 76 | 25495711 |
US |
5 | 2 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 77 | 25495747 |
US |
64 | 1 |
Cardiac ablation, Product use in unapproved indication, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 78 | 25495756 |
US |
42 | 1 |
Rash erythematous, Skin burning sensation, Condition aggravated, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 79 | 25495770 |
US |
2 | |
Treatment failure, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 80 | 25495772 |
US |
62 | 2 |
Infection, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 81 | 25495794 |
US |
16 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 82 | 25495803 |
US |
83 | 2 |
Fatigue, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 83 | 25495815 |
US |
89 | 2 |
Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 84 | 25495823 |
US |
19 | 2 |
Dry eye, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 85 | 25495843 |
US |
44 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 86 | 25495848 |
US |
64 | 2 |
Acne, Contusion, Paraesthesia, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 87 | 25495855 |
US |
62 | 1 |
Injection site pain, Product preparation error, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 88 | 25495870 |
US |
61 | 1 |
Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 89 | 25495879 |
US |
23 | 2 |
Rebound eczema, Asthma, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 90 | 25495980 |
US |
46 | 2 |
Benign familial pemphigus, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 25496064 |
US |
27 | 2 |
Sjogren^s syndrome, Condition aggravated, Drug ineffective for unapproved indication, Product use in unapproved indication, |
||||
ERGOCALCIFEROL, NORGESTIMATE AND ETHINYL ESTRADIOL, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, CERTOLIZUMAB PEGOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 92 | 25496100 |
US |
72 | 2 |
Rebound eczema, Dry eye, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 93 | 25496128 |
8 | ||
Product use in unapproved indication, Acute graft versus host disease in liver, Acute graft versus host disease in skin, Drug ineffective, Cytomegalovirus infection, Acute graft versus host disease in intestine, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, THIOTEPA, BRINCIDOFOVIR, BRINCIDOFOVIR, GANCICLOVIR SODIUM, GANCICLOVIR, GANCICLOVIR SODIUM, GANCICLOVIR, CIDOFOVIR ANHYDROUS, CIDOFOVIR ANHYDROUS, FOSCARNET SODIUM, FOSCARNET SODIUM, |
||||
| 94 | 25496143 |
US |
2 | |
Vomiting, Intentional product misuse, Product use in unapproved indication, |
||||
LEVONORGESTREL, |
||||
| 95 | 25496155 |
US |
19 | 2 |
Menstruation delayed, Dysmenorrhoea, Vaginal haemorrhage, Intentional product misuse, Product use in unapproved indication, |
||||
LEVONORGESTREL, NORETHINDRONE AND ETHINYL ESTRADIOL, |
||||
| 96 | 25496176 |
US |
81 | 1 |
Renal failure, Product use in unapproved indication, Drug ineffective for unapproved indication, Diarrhoea, |
||||
MILTEFOSINE, SULFADIAZINE, VORICONAZOLE, FLUCYTOSINE, |
||||
| 97 | 25496244 |
CA |
80 | 1 |
Myasthenia gravis, Iron deficiency, Nausea, Neuralgia, Incorrect route of product administration, Intentional product misuse, Off label use, Product use in unapproved indication, |
||||
HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DOBUTAMINE, DOBUTAMINE, DOBUTAMINE, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, THEOPHYLLINE, THEOPHYLLINE, THEOPHYLLINE, THEOPHYLLINE, THEOPHYLLINE, THEOPHYLLINE, THEOPHYLLINE, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, |
||||
| 98 | 25496299 |
US |
||
Spinal meningioma benign, Malaise, Headache, Dyspnoea, Mobility decreased, Memory impairment, Product use in unapproved indication, |
||||
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 99 | 25496302 |
US |
53 | 1 |
Injection site rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 100 | 25496391 |
US |
70 | 2 |
Product use in unapproved indication, Extra dose administered, |
||||
DUPILUMAB, DUPILUMAB, DONEPEZIL HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYZINE, LOSARTAN, EVOLOCUMAB, TIZANIDINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29